丽珠医药(01513) - 致登记股东之通知信函 - 刊发2025中期报告

麗 珠 醫 藥 集 團 股 份 有 限 公 司 LIVZON PHARMACEUTICAL GROUP INC.* (a joint stock company incorporated in the People's Republic of China with limited liability) 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 (Stock code 股份代號: 1513) NOTIFICATION LETTER 通知信函 29 August 2025 Dear Registered Shareholder, Livzon Pharmaceutical Group Inc. (the "Company") Notification of publication of Interim Report 2025 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications are now av ...